Online: 4th Jan 2023 – 2nd Mar 2023
ABOUT MENAP SMI
Our Vision, Mission and Objectives
MENAP-SMI (Middle East, North Africa, Pakistan Self Medication Industry) is a not-for-profit organization which represents manufacturers of non-prescription medicines, food supplements and self-care medical devices (all also designated as Consumer Health Products), based in the MENAP region.
The mission of MENAP-SMI is to promote better health through responsible self-medication and personal well-being.
MENAP-SMI works to creating a partnership with governments and other stakeholders and acts in the best interests of patients, consumers, and industry.
- Conduct scientific research, economic analysis & communication actions promoting responsible self-medication
- Provide strategic support to members and be the self-medication industry representative vis a vis the official bodies in MENAP region
- Organize meetings and conferences with key stakeholders in the self-care industry
- Cooperate with public authorities, local and regional associations linked to self-care industry
The Role of Self-Care in
Universal Health Coverage
What is UHC, and why is it important?
Universal health coverage (UHC) ensures all people, everywhere, can access quality essential health services with financial protection. It is firmly rooted in the human right to health and requires strong political leadership. Because affordable, accessible, quality health services unlock people’s potential, UHC is one of the smartest investments countries can make. And nearly all countries, including low income countries, have the capacity to mobilise the resources required to achieve UHC. Achieving UHC is essential for inclusive development, prosperity, gender equality and fairness.
THE ECONOMICS OF SELF-CARE
Study Overview and objectives
In order to demonstrate the potential economic and societal benefits of an increase in the number and variety of OTC medicines for consumers and patients in Mexico, Bayer commissioned a study (Sep-Dec´16) to quantify the cost differences between OTC self-care versus the costs for treatment through Mexico’s public health systems for several common, non-serious conditions.
Our Board of Directors
Regulatory Affairs & Medical Services Director, ME, Africa, Turkey, West Asia at Reckitt Benckiser.